StonvexLoading…
StonvexStonvexStonvexCore line items from CSTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.45B | $7.33B | $7.83B | $8.53B |
Operating Income | $408.00M | $135.00M | $232.00M | $150.00M |
Net Income | $273.00M | $56.00M | $152.00M | $308.00M |
EPS (Diluted) | $1.92 | $0.38 | $1.03 | $2.10 |
Total Assets | $5.35B | $4.73B | $4.93B | $4.94B |
Total Liabilities | $4.38B | $4.01B | $4.19B | $4.19B |
Cash & Equivalents | $120.00M | $141.00M | $223.00M | $176.00M |
Free Cash Flow OCF − CapEx | $159.00M | $-112.00M | $66.00M | $76.00M |
Shares Outstanding | 135.42M | 143.52M | 148.47M | 146.96M |